Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA
Status:
Completed
Trial end date:
2018-03-14
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label, parallel group study to compare systemic exposure of
triamcinolone acetonide following administration into both knees of either FX006 or TAcs.